A Phase IIb Study of AZD5462 in Patients with Chronic Heart Failure

Trial Identifier: D9090C00008
Sponsor: AstraZeneca
Start Date: June 2024
Primary Completion Date: February 2026
Study Completion Date: February 2026
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
BG Pleven, BG, 5800
BG Sofia, BG, 1527
BG Sofia, BG, 1431
BG Sofia, BG, 1309
CZ Brno, CZ, 625 00
CZ Jaromer, CZ, 55101
CZ Liberec 2, CZ, 460 01
CZ Louny, CZ, 440 01
CZ Plzeň, CZ, 301 00
DK Aalborg, DK, 9000
DK Herning, DK, 7400
HU Balatonfüred, HU, 8230
HU Kistarcsa, HU, 2143
HU Nyíregyháza, HU, 4400
HU Székesfehérvár, HU, 8000
IN Kochi, IN, 682018
IN Kolkata, IN, 700020
IN Surat, IN, 395001
IN Vadodara, IN, 390022
JP Fukui-shi, JP, 910-8526
JP Higashiibaraki-gun, JP, 311-3193
JP Higashiohmi-shi, JP, 527-8505
JP Kitakyushu, JP, 802-8555
JP Kobe, JP, 654-0155
JP Kumamoto, JP, 861-4193
JP Miyazaki-shi, JP, 880-0834
JP Morioka-shi, JP, 020-0066
JP Naha, JP, 902-8511
JP omihachiman-shi, JP, 523-0082
JP Shunan, JP, 745-8522
NL BREDA, NL, 4818 CK
NL DEVENTER, NL, 7416 SE
NL Enschede, NL, 7512 KZ
PL Kraków, PL, 30-082
PL Kraków, PL, 31-271
PL Łódź, PL, 93-513
PL Warszawa, PL, 01-249
PL Wrocław, PL, 50-556
PL Wrocław, PL, 50-981
SK Bratislava, SK, 813 69
SK Bratislava, SK, 821 07
SK Kosice, SK, 044 24
US, AL Alexander City, AL, US, 35010
US, CA Northridge, CA, US, 91325
US, CA Torrance, CA, US, 90502
US, CA Vista, CA, US, 92081
US, FL Miami, FL, US, 33133
US, FL Miami Beach, FL, US, 33140
US, IN Richmond, IN, US, 47374
US, MA Boston, MA, US, 02114
US, NC Chapel Hill, NC, US, 27599
US, NY Buffalo, NY, US, 14215
US, NY Rosedale, NY, US, 11422
US, PA Philadelphia, PA, US, 19107
US, TN Knoxville, TN, US, 37916
US, VA Manassas, VA, US, 20109